, the controversial DNA-gathering company that was acquired last August, reported a $27 million loss in the year prior to its sale as net liabilities rose to $67.6 million.
Genuity Science Ireland, which is leading a programme to gather the DNA of one-tenth of the Irish population for private research, was acquired in an all-stock deal by US group, HiberCell, in a transaction that involved theThe company was formally known as WuXi NextCode and had Chinese backing. It bought Dublin-founded Genomics Medicines Ireland in 2015 in a $400 million investment that included participation from Isif.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: